A preliminary study published by Israel’s Sheba medical centre found that a fourth dose of the COVID-19 vaccine administered to people 60 years and over, made them three times more resistant to serious illness and twice as resistant to infection than thrice-vaccinated people in the same age group.  

Moving forward, Pfizer’s chief executive Albert Bourla said annual COVID-19 vaccine boosters would be preferable to more frequent boosters

At this stage, Pfizer is nearly ready to file for approval for a redesigned vaccine that targets Omicron while still protecting against other variants.  

To read the full article, follow the link below: 

Fourth COVID vaccine shot found to be highly effective